News Roundup: July 11 to July 15


Your weekly roundup of the latest news from Drug Topics®.

FDA Issues EUA for Novavax COVID-19 Vaccine, Adjuvanted

Adults aged 18 and older are eligible to receive the vaccine.

Read More

Helping Patients Manage Diabetes Burnout

Over time, the emotional burden of managing the disease can become overwhelming.

Read More

Prescription to OTC Switches A Boon for Pharmacy Front End

Medications that switch from prescription-only to OTC can be stocked in the pharmacy’s front end.

Read More

Specialty Drug Pipeline Updates for 2022

The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.

Read More

Novel, Dual-Targeted Treatment for T2D Is FDA Approved

Tirzepatide is a once-weekly subcutaneous injection to treat type 2 diabetes in conjunction with diet and exercise.

Read More

Related Videos
© 2024 MJH Life Sciences

All rights reserved.